SEO URLwww.firestrike.ai/deals/insilico-medicine-servier-acquisition-2026
acquisitionAnnounced · Jan 4, 2026Drug Discovery and DevelopmentSource · SpeculativeArticle · Factual
Servier acquires Insilico Medicine
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$888M
Target
Insilico Medicine
HK:IS · Cambridge, Massachusetts
Acquirer
Servier
Financial Stake
Status
Announced
Servier agreed to acquire Insilico Medicine. Reported deal value: $888M. Status: Announced. Sector: Drug Discovery and Development. Target headquarters context: Cambridge, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-01-04. Figures and status may change as filings and press coverage update.
January 4, 2026 Image courtesy of Insilico Medicine Days after going public on the Hong Kong Stock Exchange, Insilico Medicine has struck a multi-year oncology drug discovery partnership with France Servier worth up to $888 million
Deal timeline
Announced
Jan 4, 2026 · drugdiscoverytrends.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Drug Discovery and Development with a reported deal value of $888M. Figures and status may change as sources update.
Sources: drugdiscoverytrends.com · Primary article · FireStrike proprietary index